OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 8 days from acceptance to publication (median values for papers published in this journal in 2021, 1-2 days of FREE language polishing time is also included in this period).
Submission Deadline: August 15, 2021 (Open) Submit Now
James S. Rush, PhD
Immunology, Hepatology and Dermatology Franchise, Novartis Pharmaceuticals, Basel, Switzerland
Research Interests: Immune regulation; inflammation; autoimmune diseases; chronic kidney diseases; solid organ transplantation; immune co-stimulatory pathways, CD40-CD154 interactions, antibody-mediated rejection
by Christine Pham , Brett J Pierce , Simon W Yau , Jihad Georges Youssef , Ahmad Goodarzi and Howard J Huang
Received: 09 July 2021; Published: 30 August 2021; doi: 10.21926/obm.transplant.2103152
Data supporting the use of belatacept in non-abdominal organs are limited to case series and small cohorts involving patients requiring conversion due to CNI intolerance or contraindication. Review articles summarizing the efficacy of belatacept salvage therapy in lung transplantation have previously been published, however, dosing [...]
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.